Conference Coverage (CHI Vaccines)
Novel Adjuvant Induces Cellular Immune Responses
Published in Vaccine Weekly, April 22nd, 1996
The antigen has the extraordinary ability to stimulate T-helper type 1 (Th1)-mediated cellular immune responses in the absence of Th2-mediated antibody responses.
Because of this immunological profile, the antigen could be used as an adjuvant for therapeutic vaccines in which cytotoxic lymphocyte (CTL) responses are desired. This is precisely the goal of most therapeutic cancer vaccine strategies.
The antigen, dubbed LeIF, is derived from Leishmania protozoa, said Kenneth H. Grabstein, vice president of Coriza...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (1996-04-22)
More Articles from Vaccine Weekly
- Conference Coverage (CHI Vaccines)
Antigen-Enhanced Bacteria Improve Inactivated Whole-Cell Vaccines - Conference Coverage (CHI Vaccines)
Chimeric Mengo Virus Vaccines for HIV, Malaria, and More - Conference Coverage (IBC Vaccines)
Self Vs. Non-Self Model of Immunity Rejected - HIV Vaccines
Vaccine That Could Prevent or Delay HIV Disease Called "Realistic" - Conference Coverage (IBC Hepatitis)
Experimental HBV Vaccine Shows Promise - DNA Vaccines (HSV)
DNA Immunization Reduces HSV-2 Disease Burden and Recurrence - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
